News Focus
News Focus
Followers 158
Posts 6567
Boards Moderated 1
Alias Born 08/06/2004

Re: TTTav66 post# 266570

Friday, 08/21/2020 7:51:08 PM

Friday, August 21, 2020 7:51:08 PM

Post# of 518936

Australian specialist pharmaceutical wholesaler and distributor, HL Pharma, announced this past week:
Quote:
Anavex Life Sciences and HL Pharma
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

Supplies are being made under The TGA Special Access Scheme regulations.

https://www.anavex.com/anavex-life-sciences-receives-tga-special-access-scheme-approval-for-anavex2-73-blarcamesine-for-alzheimers-disease-patients/

https://www.9news.com.au/national/rett-syndrome-alzheimers-drug-medical-testing-underway-on-girls-sydney/c28040fa-31e9-45fd-89d3-d180b3a4ff24
Anavex utilizes precision genetic medicine to treat severe and devastating neurological disorders and is focusing on rare diseases with no available therapy (Rett syndrome) as well as neurodegenerative diseases that are on the rise due to ageing populations (Parkinson’s Disease and Alzheimer’s Disease)

https://hlpharma.com.au/anavex-life-sciences-and-hl-pharma/




Very interesting find TTT, a connecting dot, Looking at that 3rd link things are moving forward at a very nice pace indeed.

A big dot in connecting the logistics from drug mfg to patient.

3rd link:
"Anavex Life Sciences and HL Pharma
HL Pharma is pleased to announce we are working with Anavex Life Sciences Corporation to facilitate the ongoing supply of medication to patients post clinical trial completions for Rett Syndrome and the treatment of Alzheimer’s Disease.

Supplies are being made under The TGA Special Access Scheme regulations."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News